A detailed history of Trexquant Investment LP transactions in Axogen, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 45,905 shares of AXGN stock, worth $835,930. This represents 0.01% of its overall portfolio holdings.

Number of Shares
45,905
Previous 11,262 307.61%
Holding current value
$835,930
Previous $81,000 693.83%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.52 - $14.69 $260,515 - $508,905
34,643 Added 307.61%
45,905 $643,000
Q2 2024

Aug 13, 2024

BUY
$5.67 - $8.06 $63,855 - $90,771
11,262 New
11,262 $81,000
Q1 2023

May 15, 2023

SELL
$7.53 - $10.95 $93,650 - $136,185
-12,437 Reduced 48.92%
12,987 $122,000
Q4 2022

Feb 13, 2023

BUY
$9.44 - $13.09 $131,121 - $181,820
13,890 Added 120.43%
25,424 $253,000
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $93,886 - $141,291
11,534 New
11,534 $137,000
Q2 2022

Aug 11, 2022

SELL
$6.99 - $10.0 $301,954 - $431,980
-43,198 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$7.26 - $10.7 $313,617 - $462,218
43,198 New
43,198 $343,000
Q4 2020

Feb 11, 2021

SELL
$11.5 - $17.96 $369,978 - $577,809
-32,172 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$10.62 - $13.12 $341,666 - $422,096
32,172 New
32,172 $374,000
Q2 2020

Aug 07, 2020

SELL
$7.35 - $10.81 $87,906 - $129,287
-11,960 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$8.38 - $17.34 $100,224 - $207,386
11,960 New
11,960 $124,000
Q2 2019

Aug 09, 2019

SELL
$18.5 - $25.47 $355,773 - $489,813
-19,231 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$14.62 - $22.13 $14,239 - $21,554
-974 Reduced 4.82%
19,231 $405,000
Q4 2018

Feb 13, 2019

BUY
$17.09 - $38.25 $345,303 - $772,841
20,205 New
20,205 $413,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $770M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.